Finzati - Logo
PCYO logo

Pure Cycle Corporation

PCYORegulated Water
$11.19
+0.07 (+0.63%)
Current price
EarningsLatest report: Feb 28, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$270.48M
Growth
Cash Flow
3/5
Trend
Mostly stable
Evidence
Stable or improving margins · 50.3%Positive revenue growth · 10.9%Positive free cash flow · 0.15Reasonable earnings multiple · 18.55Manageable debt level · 0.05
Financial data as of: Feb 28, 2026, 12:00 AM UTCLast earnings update: Apr 8, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$11.19
Change0.63%
Shares Out24.17M
Market Cap$270.48M
Enterprise Value$273.64M
52W Range9.65 - 12.44
Beta1.23
P/E19.27
P/S8.83
P/B1.82
P/FCF-2,436.78
EV/Sales8.93

Investment DNA

How strong this company looks for long-term investors

74
out of 100
Business Quality
Margins, moat, returns
85/100
Financial Strength
Debt, cash, stability
95/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
56/100
Why this score
Stable or improving margins · 50.3%Positive revenue growth · 10.9%Positive free cash flow · 0.15Reasonable earnings multiple · 18.55Manageable debt level · 0.05Healthy liquidity · 2.72

Analyst view

Analyst sentiment and price target

PCYO
Analyst sentiment
Based on 1 analyst votes · 2026-09-05
100/100
Bullish
Bullish
1
Hold
0
Bearish
0

Company Overview

IPO: 4/13/1994
Industry: Regulated Water
P/B i: 1.82
Debt / Equity i: 0.05
Operating Margin: 29.40%
Net Margin: 50.25%
ROE i: -
ROIC: -

Financial Health

Score19 / 20
Debt / Equity: 0.05
Current Ratio: 2.72
Quick Ratio: 2.09
Status: Strong

Insider Transactions

Recent executive and insider activity

2 high-volume insider sells detected
Kozlowski Daniel R
Transaction: 01/14/2026
BUY
Change
+2,653
Price
Not reported
Filing
01/16/2026
Type
BUY
FENDEL FREDERICK A. III
Transaction: 01/14/2026
BUY
Change
+2,653
Price
Not reported
Filing
01/15/2026
Type
BUY
Sheets Jeffrey G
Transaction: 01/14/2026
BUY
Change
+2,653
Price
Not reported
Filing
01/15/2026
Type
BUY